Search
Vera Therapeutics Inc
VERAAdd to Watchlist
33.050USD
-3.210-8.85%
Close 09-23 16:00（ET）
2.37BMarket Cap
LossP/E TTM
Vera Therapeutics Inc (VERA) Stock Price Target & Forecast
Analyst Rating
Based on 14 analysts giving stock ratings to Vera Therapeutics Inc in the past month.
Buy
5 Strong Buy
8 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
77.077USD+112.57%
VERA Analyst Recommendation Trends
In the current month, VERA has received 8 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. VERA average Analyst price target in the last month is 77.077.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
5
5
5
5
5
5
4
4
8
8
8
8
8
8
8
8
1
1
1
1
1
1
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14
14
14
14
14
14
14
14
Financial Forecasting
Based on analysts' estimates, VERA EPS is projected to reach -1.610 in FY2026Q3, following reported EPS of -1.524 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.28
-1.33
-1.58
-1.61
-1.48
Actual
-1.39
-1.69
-1.52
--
--
Surprise
-8.31%
-27.60%
+3.33%
--
--
FAQs
What is Vera Therapeutics Inc's price target?
Analysts forecast that Vera Therapeutics Inc's price target is USD 62.50, with the highest forecast at USD 100.00 and the lowest forecast at USD 23.00.
How have Vera Therapeutics IncVERA's recent earnings per share performed?
The market expectation was USD -1.52, while Vera Therapeutics IncVERA's earnings per share (EPS) for the previous quarter was USD -1.69. EPS for the next quarter is expected at USD -1.61.
What is the analyst rating for Vera Therapeutics Inc?
Based on the ratings of Vera Therapeutics Inc's stock from 14 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.